Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.

Pavlina Janovska; Jan Verner; Jiri Kohoutek; Lenka Bryjova; Michaela Gregorova; Marta Dzimkova; Hana Skabrahova; Tomasz Radaszkiewicz; Petra Ovesna; Olga Vondalova Blanarova; Tereza Nemcova; Zuzana Hoferova; Katerina Vasickova; Lucie Smyckova; Alexander Egle; Sarka Pavlova; Lucie Poppova; Karla Plevova; Sarka Pospisilova; Vitezslav Bryja

doi:10.1182/blood-2017-05-786947

Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.

Pavlina Janovska
, Jan Verner
, Jiri Kohoutek
, Lenka Bryjova
, Michaela Gregorova
, Marta Dzimkova
, Hana Skabrahova
, Tomasz Radaszkiewicz
, Petra Ovesna
, Olga Vondalova Blanarova
, Tereza Nemcova
, Zuzana Hoferova
, Katerina Vasickova
, Lucie Smyckova
, Alexander Egle (Co-author)
, Sarka Pavlova
, Lucie Poppova
, Karla Plevova
, Sarka Pospisilova
, Vitezslav Bryja

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

46 Citations (Web of Science)

Original language	English
Pages (from-to)	1206-1218
Journal	BLOOD
Volume	131
Issue number	11
DOIs	https://doi.org/10.1182/blood-2017-05-786947
Publication status	Published - 2018

Keywords

RECEPTOR TYROSINE KINASE
CELL POLARITY PATHWAY
IN-VITRO
MOUSE MODEL
B-CELLS
HEMATOLOGICAL MALIGNANCIES
SURFACE EXPRESSION
CANCER-CELLS
ROR1
INHIBITION

Access to Document

10.1182/blood-2017-05-786947

Cite this

Janovska, P., Verner, J., Kohoutek, J., Bryjova, L., Gregorova, M., Dzimkova, M., Skabrahova, H., Radaszkiewicz, T., Ovesna, P., Vondalova Blanarova, O., Nemcova, T., Hoferova, Z., Vasickova, K., Smyckova, L., Egle, A., Pavlova, S., Poppova, L., Plevova, K., Pospisilova, S., & Bryja, V. (2018). Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia. BLOOD , 131(11), 1206-1218. https://doi.org/10.1182/blood-2017-05-786947

Janovska, Pavlina ; Verner, Jan ; Kohoutek, Jiri et al. / Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia. In: BLOOD 2018 ; Vol. 131, No. 11. pp. 1206-1218.

@article{2229187ff09c402e8f26841f970564f4,

title = "Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.",

keywords = "RECEPTOR TYROSINE KINASE, CELL POLARITY PATHWAY, IN-VITRO, MOUSE MODEL, B-CELLS, HEMATOLOGICAL MALIGNANCIES, SURFACE EXPRESSION, CANCER-CELLS, ROR1, INHIBITION",

author = "Pavlina Janovska and Jan Verner and Jiri Kohoutek and Lenka Bryjova and Michaela Gregorova and Marta Dzimkova and Hana Skabrahova and Tomasz Radaszkiewicz and Petra Ovesna and \{Vondalova Blanarova\}, Olga and Tereza Nemcova and Zuzana Hoferova and Katerina Vasickova and Lucie Smyckova and Alexander Egle and Sarka Pavlova and Lucie Poppova and Karla Plevova and Sarka Pospisilova and Vitezslav Bryja",

note = "Egle: Paracelsus Med Univ, Salzburg, Austria",

year = "2018",

doi = "10.1182/blood-2017-05-786947",

language = "English",

volume = "131",

pages = "1206--1218",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "11",

}

Janovska, P, Verner, J, Kohoutek, J, Bryjova, L, Gregorova, M, Dzimkova, M, Skabrahova, H, Radaszkiewicz, T, Ovesna, P, Vondalova Blanarova, O, Nemcova, T, Hoferova, Z, Vasickova, K, Smyckova, L, Egle, A, Pavlova, S, Poppova, L, Plevova, K, Pospisilova, S & Bryja, V 2018, 'Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.', BLOOD , vol. 131, no. 11, pp. 1206-1218. https://doi.org/10.1182/blood-2017-05-786947

Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia. / Janovska, Pavlina; Verner, Jan; Kohoutek, Jiri et al.
In: BLOOD , Vol. 131, No. 11, 2018, p. 1206-1218.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia.

AU - Janovska, Pavlina

AU - Verner, Jan

AU - Kohoutek, Jiri

AU - Bryjova, Lenka

AU - Gregorova, Michaela

AU - Dzimkova, Marta

AU - Skabrahova, Hana

AU - Radaszkiewicz, Tomasz

AU - Ovesna, Petra

AU - Vondalova Blanarova, Olga

AU - Nemcova, Tereza

AU - Hoferova, Zuzana

AU - Vasickova, Katerina

AU - Smyckova, Lucie

AU - Egle, Alexander

AU - Pavlova, Sarka

AU - Poppova, Lucie

AU - Plevova, Karla

AU - Pospisilova, Sarka

AU - Bryja, Vitezslav

N1 - Egle: Paracelsus Med Univ, Salzburg, Austria

PY - 2018

Y1 - 2018

KW - RECEPTOR TYROSINE KINASE

KW - CELL POLARITY PATHWAY

KW - IN-VITRO

KW - MOUSE MODEL

KW - B-CELLS

KW - HEMATOLOGICAL MALIGNANCIES

KW - SURFACE EXPRESSION

KW - CANCER-CELLS

KW - ROR1

KW - INHIBITION

U2 - 10.1182/blood-2017-05-786947

DO - 10.1182/blood-2017-05-786947

M3 - Original Article

C2 - 29317454

SN - 0006-4971

VL - 131

SP - 1206

EP - 1218

JO - BLOOD

JF - BLOOD

IS - 11

ER -

Janovska P, Verner J, Kohoutek J, Bryjova L, Gregorova M, Dzimkova M et al. Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia. BLOOD . 2018;131(11):1206-1218. doi: 10.1182/blood-2017-05-786947